Evercore Investment Banking Pitch Book slide image

Evercore Investment Banking Pitch Book

Executive Summary Introduction Evercore Group L.L.C. ("Evercore") is pleased to provide the following materials to the Conflicts Committee (the "Conflicts Committee") of the Board of Directors of Sisecam Resource Partners LLC (the "Partnership GP"), the general partner of Sisecam Resources LP ("SIRE" or the "Partnership"), regarding Sisecam Chemicals Resources LLC's ("Sisecam Chemicals" or "SCR") proposal to acquire all the outstanding common units representing limited partner interests in the Partnership (each, a "Common Unit") Pursuant to the Agreement and Plan of Merger, dated as of the date hereof (the "Agreement"), among the Partnership, the Partnership GP, Sisecam Chemicals Wyoming LLC ("Parent"), and Sisecam Chemicals Newco LLC, an indirect wholly- owned subsidiary of Parent ("Merger Sub"), Merger Sub will merge with and into the Partnership, with the Partnership surviving and continuing to exist as a Delaware limited partnership and a wholly-owned subsidiary of Parent (the "Transaction") As a result of the Transaction, each outstanding Common Unit, other than the Common Units owned by Parent and its permitted transferees will be converted into a right to receive $25.00 in cash, without interest (the "Consideration"), per issued and outstanding Common Unit Parent is a wholly-owned subsidiary of Sisecam Chemicals that currently owns: 14,551,000 Common Units (72% limited partner interest in the Partnership) The Partnership GP, which owns a 2.0% general partner interest in the Partnership Holders of Common Units other than the Partnership GP, Parent, Merger Sub and their respective affiliates are referred to as the "Unaffiliated Unitholders" On July 5, 2022, Sisecam Chemicals proposed to acquire each outstanding Common Unit owned by the Unaffiliated Unitholders for $17.90 per Common Unit in cash (the "Initial Proposal") On January 31, 2023, Sisecam Chemicals and the Conflicts Committee reached a tentative agreement whereby Sisecam Chemicals will acquire each outstanding Common Unit owned by the Unaffiliated Unitholders at $25.00 per Common Unit in cash with quarterly distributions to be paid through and until the closing date on a pro rata basis (the "Consideration") The Consideration represents a 39.3% premium to SIRE's closing Common Unit price of $17.95 as of July 5, 2022, the last unaffected trading date before public announcement of the Initial Proposal The Consideration represents a 39.9% premium to SIRE's 30-day volume weighted average price ("VWAP") as of July 5, 2022 of $17.87 EVERCORE 1 ŞİŞECAM
View entire presentation